National Institutes of Health (NIH) β 2014 Investments
181 investments dated 2014 Β· listed companies and verified rows first Β· show all
Aronora is a clinical-stage biotech developing antithrombotic therapies, including factor XI/XIa inhibitors and thrombolytic drug candidates, to treat and manage thrombotic and thromboembolic conditions such as acute ischemic stroke, heart attack, and pulmonary embolism.
BiotechDeep TechHealthtechPortland, US
Erik I. Tucker(President & Chief Executive Officer)
Biopharmaceutical company using computational biology to identify and develop novel peptide therapies, including AXT107 for retinal/eye diseases.
BiotechBethesda, US
Aleksander S. Popel, PhD(Executive Officer, Director)Jordan J. Green(Executive Officer, Director)Wendy Perrow(Executive Officer, Director)
Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions.
BiotechDeep TechMedical Devices
Florian Solzbacher(Co-Founder & CSO)Marcus Gerhardt(Co-Founder & CEO)Thomas Thiele(CFO)Christian Angermayer(Co-Chairman)Tim Sievers(Co-Chairman)
Cogito, now part of Verint, provides real-time AI coaching and monitoring solutions for contact centers to improve customer and employee experience.
AI & Machine LearningEnterprise SoftwareSaaSBoston, US
Krishna Gupta(Director)Joshua Feast(Executive Officer, Director)Dustin Pederson(Executive Officer)Ali Azarbayejani(Executive Officer, Director)
Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs.
AI & Machine LearningDigital HealthHealthtechMedical DevicesWoodland Hills, US
Gaurav Agarwal(Executive Officer, Director)Mads Dall(Director)Zina Affas Besse(Director)Marie-Louise Little(Director)Kaushal Solanki(Director)
BiotechMadison, US
Dan Stinchcomb(Director)C. Boyd Clarke(Director)Phillip M. Halpern(Director)Paul V. Radspinner(Executive Officer, Director)David G. Walsh(Director)Pamuk Bilsel(Executive Officer)
Imbed Biosciences is a medical device company that develops SAMatrix, an ultra-thin, fully synthetic bioresorbable wound matrix that integrates antimicrobial silver and non-opioid pain agents (lidocaine) for treating chronic and acute wounds such as ulcers, surgical, traumatic, and burn wounds.
BiotechHealthtechMedical DevicesMadison, US
Nicholas L Abbott(Executive Officer, Director)David Guinther(Director)Robert A Beckman(Director)Ankit Agarwal(Executive Officer, Director)
Immunomic Therapeutics develops nucleic acid immunotherapy platforms, particularly self-amplifying RNA and plasmid DNA vaccines, for cancer treatment, allergies, and animal health applications.
BiotechMedical DevicesRockville, US
Dong-Gun Kim(Executive Officer, Director)WILLIAM G. HEARL(Chief Executive Officer and Director)RONALD P. THIBOUTOT(Director)WILLIAM BARRY MCDONALD(Director)C. ERIC WINZER(Chief Financial Officer and Director)MICHAEL D. LACK(Director)
Kestrel Labs develops software that translates building code into machine-executable logic and runs compliance checks directly within BIM models, integrated into tools like Autodesk Revit.
AI & Machine LearningConstruction TechDeveloper ToolsPropTechSaaSDenver, US
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
BiotechHealthtechMedical DevicesEmeryville, US
Debkishore Mitra(Founder)inSteve Tablak(Director)Justin Butler(Director)Tuff Yen(Director)John R. Waldeisen(Director)
BoardErik T. Engelson(Executive Officer, Director)
Myolex develops a portable, non-invasive electrical impedance myography (EIM) device that measures muscle composition and structure to assist in the diagnosis and monitoring of neuromuscular disorders and muscle wasting diseases.
Deep TechHealthtechMedical DevicesBrookline, US
NanoCellect manufactures microfluidic cell sorting systems for laboratory and research applications.
BiotechMedical Devices
Newomics develops the UniESI system, a multiomics front-end platform using its M3 emitter and MEA chip "multispray" technologies for microflow and nanoflow LC-MS.
BiotechDeep TechHardwareBerkeley, US
Pan Mao(Director)Patrick Scannon(Director)Daojing Wang(Executive Officer, Director)
BoardTed Hou(Director)
BiotechSeattle, US
Sharon K. Everson(Director)Walter L. Robb(Director)Kriss Hammond(Director)Thomas Neumann(Executive Officer, Director)Alan C. Nelson(Executive Officer, Director)
OmniSpeech develops speech extraction technology that reduces background noise and improves voice intelligibility across hardware and software platforms.
AI & Machine LearningEnterprise SoftwareHardwareCollege Park, US
Dr. Carol Espy-Wilson
First-in-class biologic drug targeting the CD24-Siglec innate immunity signaling pathway.
BiotechRockville, US
Pan Zheng(Executive Officer)Kun-Liang Guan(Director)Miao Hong(Director)Martin Devenport(Executive Officer)Yang Liu(Executive Officer, Director)Gary Fanger(Director)
ONL Therapeutics is a clinical-stage biopharmaceutical company developing neuroprotective treatments for retinal diseases including retinal detachment, geographic atrophy, and glaucoma.
BiotechHealthtechMedical DevicesAnn Arbor, US
David Zacks(Executive Officer)David Esposito(Executive Officer, Director)Constance Chang(Executive Officer)Loic Couraud(Director)William Brinkerhoff(Director)Mark Hooper(Director)
PreludeDx develops DCISionRT, a biomarker-based diagnostic test for ductal carcinoma in situ (DCIS) breast cancer that helps physicians predict a patient's recurrence risk and whether they would benefit from radiation therapy after breast-conserving surgery.
BiotechHealthtechMedical Devices
Provides solutions for stem cell maintenance, proliferation, differentiation, and large-scale production, including recombinant substrates and antibodies.
Seattle, US
Ronald Seubert(Executive Officer, Director, Promoter)Evan Castiglia(Executive Officer)Joseph Victor(Executive Officer, Director)Frank Witney(Director)Eric Kaldjian(Executive Officer)
BoardRobert Shepler(Director)
RIVANNA builds AI-powered ultrasound imaging platforms that provide clinical decision support at the point of care, including procedural guidance for neuraxial anesthesia (spinal needle intervention) and bedside fracture triage for emergency medicine.
AI & Machine LearningDigital HealthHealthtechMedical DevicesCharlottesville, US
Timothy R. Ober(Director)Kevin Owen(Director, Promoter)Frank William Mauldin, Jr.(Executive Officer, Director, Promoter)John A. Williams(Executive Officer)G. Wayne Moore(Director)Giorgio Brusa(Director, Promoter)
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Carole H Bellis(Executive Officer)Kevin E Healy(Director)Walter Moos(Director)Jackson M Wesley(Executive Officer, Director)Wesley Jackson(President, Chief Scientific Officer & Member of the Board)Gregory D. Kunst(Chief Executive Officer)
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that detects biological signals emitted by tumors (via absorbed radiopharmaceuticals) to deliver targeted radiation to moving lung or bone tumors from primary or metastatic cancer.
BiotechHealthtechMedical DevicesHayward, US
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.